{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:42:35Z","timestamp":1788237755044,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,5]]},"DOI":"10.7759\/cureus.81750","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T12:29:37Z","timestamp":1743856177000},"source":"Crossref","is-referenced-by-count":1,"title":["Factors Associated With Complications in Patients With Hematological Malignancies and Febrile Neutropenia: A Cohort Study"],"prefix":"10.7759","author":[{"given":"Jose C","family":"Alvarez-Payares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Alvarez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose E.","family":"Ag\u00e1mez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Hernandez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Ram\u00edrez-Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel D.","family":"Molina-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Cardona-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M.","family":"Trejos-Tenorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigifredo","family":"Ospina-Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioka","family":"de la Pe\u00f1a-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Barrera-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Ribero-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J","family":"Ariza-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amado J.","family":"Karduss-Urueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idh.2019.08.006","article-title":"Bloodstream infections in neutropenic patients with haematological malignancies","volume":"25","author":"Carvalho AS","year":"2020","unstructured":"Carvalho AS, Lagana D, Catford J, Shaw D, Bak N. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Dis Health. 2020, 25:22-9. 10.1016\/j.idh.2019.08.006","journal-title":"Infect Dis Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update","volume":"36","author":"Taplitz RA","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, et al.. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol. 2018, 36:1443-53. 10.1200\/JCO.2017.77.6211","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00269","article-title":"Optimal management of neutropenic fever in patients with cancer","volume":"15","author":"Zimmer AJ","year":"2019","unstructured":"Zimmer AJ, Freifeld AG. Optimal management of neutropenic fever in patients with cancer. J Oncol Pract. 2019, 15:19-24. 10.1200\/JOP.18.00269","journal-title":"J Oncol Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld AG","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et al.. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011, 52:e56-93. 10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti G","year":"2016","unstructured":"Gustinetti G, Mikulska M. Bloodstream infections in neutropenic cancer patients: a practical update. Virulence. 2016, 7:280-97. 10.1080\/21505594.2016.1156821","journal-title":"Virulence"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.22354\/in.v23i4.806","article-title":"Caracter\u00edsticas cl\u00ednicas y microbiol\u00f3gicas de pacientes con neutropenia febril en un hospital universitario","volume":"23","author":"Garz\u00f3n J","year":"2019","unstructured":"Garz\u00f3n J, Isaza N, Posada A, et al.. Caracter\u00edsticas cl\u00ednicas y microbiol\u00f3gicas de pacientes con neutropenia febril en un hospital universitario. Infectio. 2019, 23:347-57. 10.22354\/in.v23i4.806","journal-title":"Infectio"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182013000200010","article-title":"Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tob\u00f3n Uribe, Colombia","volume":"30","author":"Madrid C","year":"2013","unstructured":"Madrid C, D\u00edaz L, Combariza J, G\u00e1lvez K, Olaya V, Ram\u00edrez I, Donado J. Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tob\u00f3n Uribe, Colombia. Rev Chilena Infectol. 2013, 30:195-201. 10.4067\/S0716-10182013000200010","journal-title":"Rev Chilena Infectol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224299","article-title":"A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period","volume":"14","author":"Parodi RL","year":"2019","unstructured":"Parodi RL, Lagrutta M, Tortolo M, et al.. A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period. PLoS One. 2019, 14:e0224299. 10.1371\/journal.pone.0224299","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-21859-1_8","article-title":"Neutropenic Fever","author":"Baluch A","year":"2019","unstructured":"Baluch A, Shewayish S. Neutropenic Fever. Infections in Neutropenic Cancer Patients.  Springer, Cham; 2019. 105-17. 10.1007\/978-3-030-21859-1_8"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.08.024","article-title":"The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease","volume":"34","author":"Park Y","year":"2010","unstructured":"Park Y, Kim DS, Park SJ, et al.. The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease. Leuk Res. 2010, 34:294-300. 10.1016\/j.leukres.2009.08.024","journal-title":"Leuk Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The multinational association for supportive care in Cancer Risk Index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky J","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB, et al.. The multinational association for supportive care in Cancer Risk Index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000, 18:3038-51. 10.1200\/JCO.2000.18.16.3038","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.17533\/udea.iatreia.4449","article-title":"Caracter\u00edsticas cl\u00ednicas y microbiol\u00f3gicas de los pacientes neutrop\u00e9nicos febriles con neoplasias hematol\u00f3gicas (Spanish)","volume":"21","author":"Mu\u00f1oz-Maya O","year":"2008","unstructured":"Mu\u00f1oz-Maya O, Rodelo-V\u00e9lez A, Carvajal J, Gonz\u00e1lez J, Jaimes-Barragan F. Caracter\u00edsticas cl\u00ednicas y microbiol\u00f3gicas de los pacientes neutrop\u00e9nicos febriles con neoplasias hematol\u00f3gicas (Spanish). Iatreia. 2008, 21:9. 10.17533\/udea.iatreia.4449","journal-title":"Iatreia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01250-19","article-title":"Shock and early death in hematologic patients with febrile neutropenia","volume":"63","author":"Guarana M","year":"2019","unstructured":"Guarana M, Nucci M, Nou\u00e9r SA. Shock and early death in hematologic patients with febrile neutropenia. Antimicrob Agents Chemother. 2019, 63:e01250-19. 10.1128\/AAC.01250-19","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43898","article-title":"Microbiological spectrum of neutropenic sepsis in cancer patients admitted to a tertiary health care centre","volume":"15","author":"John KR","year":"2023","unstructured":"John KR, Warrier A, Warrier A. Microbiological spectrum of neutropenic sepsis in cancer patients admitted to a tertiary health care centre. Cureus. 2023, 15:e43898. 10.7759\/cureus.43898","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2022.100296","article-title":"Clinical factors predictive of recurrent febrile neutropenia in adult patients with acute leukemia","volume":"17","author":"Wanitpongpun C","year":"2022","unstructured":"Wanitpongpun C, Teawtrakul N, Lanamtieng T, Chansung K, Sirijeerachai C, Amampai W, Sawanyawisuth K. Clinical factors predictive of recurrent febrile neutropenia in adult patients with acute leukemia. Leuk Res Rep. 2022, 17:100296. 10.1016\/j.lrr.2022.100296","journal-title":"Leuk Res Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-010-0029-z","article-title":"Microbial etiology of febrile neutropenia","volume":"26","author":"Swati M","year":"2010","unstructured":"Swati M, Gita N, Sujata B, Farah J, Preeti M. Microbial etiology of febrile neutropenia. Indian J Hematol Blood Transfus. 2010, 26:49-55. 10.1007\/s12288-010-0029-z","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2015.409","article-title":"Investigating the presence of fungal agents in febrile neutropenic patients using different microbiological, serological, and molecular methods","volume":"15","author":"S\u00f6nmez A","year":"2015","unstructured":"S\u00f6nmez A, Eksi F, Pehlivan M, Haydaroglu Sahin H. Investigating the presence of fungal agents in febrile neutropenic patients using different microbiological, serological, and molecular methods. Bosn J Basic Med Sci. 2015, 15:40-7. 10.17305\/bjbms.2015.409","journal-title":"Bosn J Basic Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.12520","article-title":"Evaluation of risk factors for mortality in febrile neutropenia","volume":"14","author":"Ceken S","year":"2020","unstructured":"Ceken S, Gedik H, Iskender G, et al.. Evaluation of risk factors for mortality in febrile neutropenia. J Infect Dev Ctries. 2020, 14:886-92. 10.3855\/jidc.12520","journal-title":"J Infect Dev Ctries"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2021.09.002","article-title":"Mortality-associated clinical risk factors in patients with febrile neutropenia: a retrospective study","volume":"1","author":"Sereeaphinan C","year":"2021","unstructured":"Sereeaphinan C, Kanchanasuwan S, Julamanee J. Mortality-associated clinical risk factors in patients with febrile neutropenia: a retrospective study. IJID Reg. 2021, 1:5-11. 10.1016\/j.ijregi.2021.09.002","journal-title":"IJID Reg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2040","article-title":"Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department","volume":"31","author":"Lynn JJ","year":"2013","unstructured":"Lynn JJ, Chen KF, Weng YM, Chiu TF. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department. Hematol Oncol. 2013, 31:189-96. 10.1002\/hon.2040","journal-title":"Hematol Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.12.006","article-title":"Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review","volume":"90","author":"Lyman GH","year":"2014","unstructured":"Lyman GH, Abella E, Pettengell R. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review. Crit Rev Oncol Hematol. 2014, 90:190-9. 10.1016\/j.critrevonc.2013.12.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102547","article-title":"Evaluation of febrile neutropenia in hospitalized patients with neoplasia undergoing chemotherapy","volume":"11","author":"Bachlitzanaki M","year":"2023","unstructured":"Bachlitzanaki M, Aletras G, Bachlitzanaki E, et al.. Evaluation of febrile neutropenia in hospitalized patients with neoplasia undergoing chemotherapy. Microorganisms. 2023, 11:2547. 10.3390\/microorganisms11102547","journal-title":"Microorganisms"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175635","article-title":"All-cause mortality and its predictors in haemato-oncology patients with febrile neutropenia","volume":"12","author":"Shmuely H","year":"2023","unstructured":"Shmuely H, Monely L, Shvidel L. All-cause mortality and its predictors in haemato-oncology patients with febrile neutropenia. J Clin Med. 2023, 12:5635. 10.3390\/jcm12175635","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2013.0422","article-title":"Secondary infections in febrile neutropenia in hematological malignancies: more than another febrile neutropenic episode","volume":"32","author":"Demirel A","year":"2015","unstructured":"Demirel A, Tabak F, Ar MC, et al.. Secondary infections in febrile neutropenia in hematological malignancies: more than another febrile neutropenic episode. Turk J Haematol. 2015, 32:243-50. 10.4274\/tjh.2013.0422","journal-title":"Turk J Haematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605270","article-title":"Prevention of febrile neutropenia: use of prophylactic antibiotics","volume":"101 Suppl 1","author":"Cullen M","year":"2009","unstructured":"Cullen M, Baijal S. Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer. 2009, 101 Suppl 1:S11-4. 10.1038\/sj.bjc.6605270","journal-title":"Br J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/jrpp.JRPP_18_16","article-title":"Management of febrile neutropenia: a description of clinical and microbiological findings by focusing on risk factors and pitfalls","volume":"7","author":"Karimi F","year":"2018","unstructured":"Karimi F, Ashrafi F, Moghaddas A, Derakhshandeh A. Management of febrile neutropenia: a description of clinical and microbiological findings by focusing on risk factors and pitfalls. J Res Pharm Pract. 2018, 7:147-56. 10.4103\/jrpp.JRPP_18_16","journal-title":"J Res Pharm Pract"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08250-z","article-title":"Incidence and risk factors for febrile neutropenia of patients with diffuse large B-cell lymphoma receiving R-CHOP-21 in China","volume":"32","author":"Zheng W","year":"2023","unstructured":"Zheng W, Chen Z, Zhu S, et al.. Incidence and risk factors for febrile neutropenia of patients with diffuse large B-cell lymphoma receiving R-CHOP-21 in China. Support Care Cancer. 2023, 32:43. 10.1007\/s00520-023-08250-z","journal-title":"Support Care Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08071-0","article-title":"A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative","volume":"31","author":"Leon Rapoport B","year":"2023","unstructured":"Leon Rapoport B, Garcia-Morillo M, Font C, et al.. A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative. Support Care Cancer. 2023, 31:628. 10.1007\/s00520-023-08071-0","journal-title":"Support Care Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae052","article-title":"An emergent change in epidemiologic and microbiological characteristics of bloodstream infections in adults with febrile neutropenia resulting from chemotherapy for acute leukemia and lymphoma at reference centers in Chile, Ecuador, and Peru","volume":"11","author":"Rabagliati R","year":"2024","unstructured":"Rabagliati R, Salazar G, P\u00e9rez-Lazo G, et al.. An emergent change in epidemiologic and microbiological characteristics of bloodstream infections in adults with febrile neutropenia resulting from chemotherapy for acute leukemia and lymphoma at reference centers in Chile, Ecuador, and Peru. Open Forum Infect Dis. 2024, 11:ofae052. 10.1093\/ofid\/ofae052","journal-title":"Open Forum Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer NM","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006, 106:2258-66. 10.1002\/cncr.21847","journal-title":"Cancer"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.17451","article-title":"Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock","volume":"18","author":"Islas-Mu\u00f1oz B","year":"2024","unstructured":"Islas-Mu\u00f1oz B, Volkow-Fern\u00e1ndez P, Silva-Zamora J, Ram\u00edrez-Ibarguen A, Cornejo-Ju\u00e1rez P. Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock. J Infect Dev Ctries. 2024, 18:235-42. 10.3855\/jidc.17451","journal-title":"J Infect Dev Ctries"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2454-2","article-title":"C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms","volume":"23","author":"Combariza JF","year":"2015","unstructured":"Combariza JF, Lombana M, Pino LE, Arango M. C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms. Support Care Cancer. 2015, 23:1009-13. 10.1007\/s00520-014-2454-2","journal-title":"Support Care Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-009-0683-y","article-title":"Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy","volume":"15","author":"Nakagawa Y","year":"2009","unstructured":"Nakagawa Y, Suzuki K, Masaoka T. Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy. J Infect Chemother. 2009, 15:174-9. 10.1007\/s10156-009-0683-y","journal-title":"J Infect Chemother"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S241263","article-title":"Epidemiology of febrile neutropenia episodes with Gram-negative bacteria infection in patients who have undergone chemotherapy for hematologic malignancies: a retrospective study of 10 years\u2019 data from a single center","volume":"13","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Zheng Y, Dong F, et al.. Epidemiology of febrile neutropenia episodes with Gram-negative bacteria infection in patients who have undergone chemotherapy for hematologic malignancies: a retrospective study of 10 years\u2019 data from a single center. Infect Drug Resist. 2020, 13:903-10. 10.2147\/IDR.S241263","journal-title":"Infect Drug Resist"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/351187-factors-associated-with-complications-in-patients-with-hematological-malignancies-and-febrile-neutropenia-a-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T12:29:38Z","timestamp":1743856178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/351187-factors-associated-with-complications-in-patients-with-hematological-malignancies-and-febrile-neutropenia-a-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.81750","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,5]]}}}